Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.49 |
| ▸ | POLB | P06746 | 5/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 3/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.44 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17595049 | 0.78 | L3MBTL1 (0.59) | L3MBTL1KDM4EPOLBMAPTSMN1; SMN2 | |
| SCHEMBL3476583 | 0.77 | L3MBTL1 (0.52) | L3MBTL1KDM4EPOLBMAPTSMN1; SMN2 | |
| SCHEMBL24199937 | 0.76 | ERN1 (0.44) | L3MBTL1KDM4EPOLBMAPTHPGD | |
| SCHEMBL19194844 | 0.76 | L3MBTL1 (0.54) | L3MBTL1KDM4EPOLBMAPTSMN1; SMN2 | |
| SCHEMBL2108554 | 0.76 | L3MBTL1 (0.51) | L3MBTL1KDM4EPOLBMAPTSMN1; SMN2 | |
| SCHEMBL14720808 | 0.74 | L3MBTL1 (0.41) | L3MBTL1KDM4EPOLBMAPTSMN1; SMN2 | |
| SCHEMBL10727393 | 0.74 | ALDH1A1 (0.49) | L3MBTL1KDM4EPOLBMAPTNPC1 | |
| SCHEMBL28987812 | 0.72 | SMN1; SMN2 (0.66) | L3MBTL1KDM4EMAPTNPC1RAB9A | |
| SCHEMBL10505941 | 0.72 | SMN1; SMN2 (0.52) | L3MBTL1KDM4EPOLBMAPTSMN1; SMN2 | |
| SCHEMBL1645027 | 0.71 | ALDH1A1 (0.54) | L3MBTL1KDM4EPOLBMAPTNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1658282-B1 | NOVEL CHELATING AGENTS AND CHELATES AND THEIR USE | WALLAC OY (FI) | 2010-10-27 | — | — | EP | disclosed |
| EP-1658282-A1 | NOVEL CHELATING AGENTS AND CHELATES AND THEIR USE | WALLAC OY (FI) | 2006-05-24 | — | — | EP | disclosed |
| US-20050084451-A1 | Novel chelating agents and chelates and their use | WALLAC OY | 2005-04-21 | — | — | US | disclosed |
| WO-2005021538-A1 | NOVEL CHELATING AGENTS AND CHELATES AND THEIR USE | WALLAC OY (FI) | 2005-03-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050084451-A1 | Novel chelating agents and chelates and their use | DNPEP, CNBP, CLTA | L3MBTL1 1735/4885KDM4E 2934/4885POLB 360/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.